Devices · For physicians
Radial vs Focused Shockwave: Achilles Tendinopathy Protocols
Published October 4, 2026
- Typical Session Cadence
- 3 to 5 Sessions
- Energy Transmission Depth
- Superficial vs Deep Focal
- Consumable Cost Factors
- Applicator Maintenance
Standard treatment protocols recommend weekly intervals of 7 to 10 days to support tissue remodeling.
RSWT attenuates rapidly at the surface for mid-portion treatment, while FSWT converges at targeted deeper enthesopathy zones.
RSWT requires periodic projectile/barrel kit replacements, whereas FSWT involves therapy head refurbishments after set shock limits.
Radial shockwave therapy (RSWT) delivers acoustic energy pneumatically across superficial tissue planes, making it ideal for broad treatment of insertional and mid-portion Achilles tendinopathy, whereas focused shockwave therapy (FSWT) concentrates acoustic pulses at controlled deep focal zones to target recalcitrant insertional pathology or concurrent osseous changes. Selecting between or combining these modalities depends on target anatomical depth, tissue density, and whether pathology involves the mid-portion tendon body or the calcaneal enthesis. Standard clinical protocols typically prescribe 3 to 5 weekly sessions at titrated energy flux densities to stimulate neovascularization, cell proliferation, and extracellular matrix remodeling.
Acoustic Physics and Energy Propagation Mechanics
To effectively evaluate shockwave devices for chronic Achilles tendinopathy, clinicians must understand the physical differences in pulse generation and energy propagation between radial pressure waves and focused shockwaves.
Radial pressure waves (RSWT) are pneumatically generated. A compressed air system propels a projectile within a handpiece against a metallic transmitter head. This impact transfers mechanical energy into the patient's skin surface, creating a diverging acoustic wave. The peak pressure is highest at the applicator tip and dissipates rapidly as it penetrates deeper tissue. Because energy density attenuates with depth, RSWT is primary targeted at superficial soft tissues, making it well-suited for treating the mid-portion Achilles tendon located just beneath the subcutaneous layer.
In contrast, focused shockwaves (FSWT) are generated via electromagnetic, electrohydraulic, or piezoelectric mechanisms. These acoustic pulses travel at supersonic speeds, converging at a predefined focal depth beneath the skin without causing energy dispersion at the surface. Peak energy density is delivered precisely within the focal zone, enabling clinicians to treat deeper structures, dense calcifications, or periosteal tissues at the enthesis without causing superficial cutaneous trauma.
Clinical Protocol Guidelines: Mid-Portion vs. Insertional Pathology
Chronic Achilles tendinopathy manifests primarily in two distinct clinical entities: mid-portion tendinopathy (located 2 to 6 cm proximal to the calcaneal insertion) and insertional tendinopathy (occurring at the tendon-bone junction, often accompanied by retrocalcaneal bursitis or enthesophytes). Protocol parameters vary significantly based on the anatomic site and chosen wave type.
Radial Shockwave (RSWT) Protocol
For clinicians treating mid-portion chronic Achilles tendinopathy, RSWT offers broad coverage of the tendon body and surrounding paratenon. Practice specialists in sports medicine and orthopedics frequently utilize the following operational parameters:
- Frequency: 8 to 12 Hz
- Pressure: 1.8 to 3.2 bar (titrated based on patient pain threshold)
- Impulse Count: 2,000 to 3,000 shocks per session
- Treatment Cadence: 1 session per week for 3 to 5 consecutive weeks
- Patient Positioning: Prone with foot hanging comfortably over the end of the exam table in neutral dorsiflexion
- Application Technique: Continuous slow dynamic movement along the mid-portion tendon body, concentrating on localized myofascial trigger points in the gastrocnemius-soleus complex.
Focused Shockwave (FSWT) Protocol
When managing recalcitrant insertional Achilles tendinopathy—where pathology involves cortical bone changes, calcific deposits, or deep enthesopathy—focused shockwaves allow precise energy delivery directly to the enthesis.
- Energy Flux Density (EFD): 0.08 to 0.25 mJ/mm² (starting low and adjusting upwards as tolerated)
- Impulse Count: 1,500 to 2,500 shocks per session
- Focal Depth: Adjusted via standoff couplers (typically 5 mm to 15 mm penetration depth)
- Treatment Cadence: 1 session every 7 to 10 days for 3 to 4 sessions
- Application Technique: Static or micro-spherical targeting directly over the calcaneal insertion site, avoiding direct shockwave transmission to acutely inflamed bursal sacs if retrocalcaneal bursitis is dominant.
Comparative Selection Checklist for Clinical Teams
When evaluating patient presentation and device capabilities, clinical teams can use the following decision matrix to determine the optimal modality:
- Mid-Portion Achilles Tendinopathy (Non-Calcific): RSWT is typically the primary modality due to diffuse tissue involvement and superficial depth.
- Insertional Achilles Tendinopathy (With Calcification/Enthesophytes): FSWT is preferred to penetrate dense bone-tendon interfaces and target deep structural pathology.
- Severe Patient Pain Sensitivity: FSWT allows deep energy convergence with lower superficial skin sensation, whereas RSWT may cause higher surface discomfort at therapeutic bar pressures.
- High-Volume General Musculoskeletal Practice: RSWT provides versatile, lower-cost utility for broad superficial soft tissue indications across upper and lower extremities.
- Subspecialized Orthopedic & Regeneration Clinics: Dual-modality approaches (combining RSWT for surrounding muscular/paratenon hypertonicity and FSWT for structural focal lesions) offer the most comprehensive treatment capability.
Operational and Procurement Considerations for Practice Managers
From a practice operations and procurement perspective, introducing shockwave therapy requires evaluating equipment capitalization, consumable overhead, staff workflow, and patient throughput.
- Consumable Management and Maintenance Cycles: Radial shockwave devices rely on mechanical projectiles and barrels that require replacement after a specified number of total shocks (typically every 1.0 to 2.0 million impulses). Procurement teams must factor transmitter maintenance kits into recurring operating budgets. Focused shockwave devices utilize specialized therapy heads or handpieces with defined lifespan counts before refurbishing or replacement is necessary.
- Delegation and Staffing Efficiency: In many jurisdictions, radial shockwave applications can be delegated to trained clinical support staff, physical therapists, or medical assistants under physician supervision, maximizing provider face-time efficiency. Focused shockwave administration often requires direct physician or advanced practice provider oversight due to depth-specific focal targeting.
- Treatment Duration and Room Utilization: An RSWT treatment session typically takes 5 to 8 minutes of active generator time, allowing seamless integration into existing encounter schedules without creating facility bottlenecks. FSWT sessions may require slightly more setup time to calibrate focal heads and position dynamic coupling gels accurately.
Combining Shockwave Therapy with Regenerative Biologics
For advanced orthopedic practices seeking to optimize outcomes in chronic, non-healing tendinopathy, shockwave therapy serves as an effective adjuvant to regenerative biologics such as platelet-rich plasma (PRP) or amniotic allografts. Acoustic shockwaves stimulate local microcirculation, induce localized expression of growth factors (such as VEGF and PCNA), and initiate micro-disruption of degenerate extracellular matrix. Executing shockwave therapy 2 to 4 weeks prior to a biologic injection can condition the host tissue bed, while low-energy shockwave protocols post-injection can assist in directing cellular differentiation and matrix remodeling.
What This Means for Your Practice
To successfully incorporate or refine shockwave protocols for chronic Achilles tendinopathy in your clinic, consider the following action steps:
- Audit Patient Demographics: Review your current caseload to determine the ratio of mid-portion vs. insertional Achilles pathology and evaluate whether current conservative modalities are yielding adequate resolution.
- Assess Device Versatility: Determine whether a dedicated radial system, a focused unit, or a dual-technology platform aligns best with your clinical focus and capital budget.
- Standardize Clinical Protocols: Establish written operational guidelines for energy titration, impulse counts, session intervals, and post-treatment activity modifications for clinical personnel.
- Evaluate Synergistic Offerings: Explore how shockwave protocols can be paired with biologic therapies to establish comprehensive cash-pay service lines.
To learn more about evaluating shockwave technologies, reviewing clinical equipment specifications, or training your team on modern acoustic wave protocols, connect with our clinical support team at Dallas Regenerative Solutions for a detailed consultation.
Frequently asked questions
- Is radial or focused shockwave therapy better for insertional Achilles tendinopathy?
- Focused shockwave therapy (FSWT) is often preferred for insertional Achilles tendinopathy because its precise focal zone targets calcifications, enthesophytes, and deep bone-tendon junction pathology without dispersing energy into overlying superficial tissue. However, low-to-moderate energy radial shockwave therapy (RSWT) can also be effective when surface tissue tolerance is managed properly.
- How many shockwave sessions are typically required for chronic Achilles tendinopathy?
- Standard clinical protocols recommend 3 to 5 treatment sessions scheduled 7 to 10 days apart. Patients with long-standing recalcitrant tendinopathy or concomitant calcifications may require up to 6 sessions, with formal clinical re-evaluation performed 6 to 8 weeks post-treatment.
- Can shockwave therapy be integrated with platelet-rich plasma (PRP) or biologic injections?
- Yes, shockwave therapy is frequently paired with biologics such as autologous PRP or cellular matrix products. Acoustic energy stimulates localized cellular recruitment and microvascular proliferation, conditioning the extracellular matrix prior to biologic administration or promoting tissue remodeling in subsequent weeks.
- What is the primary operational difference between radial and focused shockwave devices?
- Radial devices use pneumatic compressors to drive a projectile against a transmitter head, dispersing acoustic energy broadly at superficial depths with low consumable costs. Focused devices utilize electromagnetic, electrohydraulic, or piezoelectric mechanisms to concentrate high pressure at specific focal depths, requiring specific head calibration and different capital investment structures.
